InspireMD (NSPR) Depreciation & Amortization (CF) (2010 - 2025)

InspireMD's Depreciation & Amortization (CF) history runs 11 years deep, the most recent figure standing at $143000.0 for Q4 2025.

• On a quarterly basis, Depreciation & Amortization (CF) rose 90.67% year-over-year to $143000.0 in Q4 2025; TTM through Dec 2025 was $476000.0, a 70.0% increase from a year earlier, with the FY2025 full-year figure at $476.0 million, up 70.0% from the prior year.
• Depreciation & Amortization (CF) climbed to $143000.0 in Q4 2025 per NSPR's latest filing, from $128000.0 in the prior quarter.
• Across five years, Depreciation & Amortization (CF) topped out at $143000.0 in Q4 2025 and bottomed at $33000.0 in Q2 2021.
• The 5-year median for Depreciation & Amortization (CF) is $58000.0 (2023), against an average of $68263.2.
• Across the five-year window, Depreciation & Amortization (CF) slipped 19.61% in 2022 and jumped 90.67% in 2025, its largest moves.
• Year by year, Depreciation & Amortization (CF) stood at $37000.0 in 2021, then jumped by 45.95% to $54000.0 in 2022, then advanced by 12.96% to $61000.0 in 2023, then increased by 22.95% to $75000.0 in 2024, then surged by 90.67% to $143000.0 in 2025.
• Per Business Quant, the three latest NSPR Depreciation & Amortization (CF) figures stand at $143000.0 (Q4 2025), $128000.0 (Q3 2025), and $107000.0 (Q2 2025).